Interestingly, there is also evidence that T-DXd is effective in patients with BC exhibiting low levels of HER2 protein as determined by IHC (i.e., HER2 IHC 2 + /non-amplified or IHC 1 +) [10]. The gene discussed is ERBB2; the disease is breast cancer.